The FDA has approved a kit used to prepare and inject a PET imaging agent that can ferret out rare somatostatin receptor-positive neuroendocrine tumors in adult and pediatric patients.

Radiology residency programs are barely using high-fidelity simulation training at all right now, but watch for the technology to begin changing the educational landscape for diagnostic rads-to-be in the years to come.

MIM Software announced this week it has received 510(k) clearance from the FDA. The company can now market its full product line running on tablets through thin client technology. 

Women with dense breasts are significantly better served when imaged with a combination of screening mammography and supplemental 3D automated breast ultrasound (ABUS) than when they’re imaged with screening mammography alone. 

Nancy M. Cappello, PhD, director and founder of Are You Dense and Are You Dense Advocacy, wrote a new post for The Huffington Post about the role social media has played in her own life and the role it plays in the lives of women from all over the world. She said the internet and social media have “transformed our lives,” opening “a global connection to those with similar interests and passions.” 

The U.S. Food & Drug Administration (FDA) approved a new radioactive diagnostic agent for use in PET imaging to identify suspected sites of prostate cancer.

A researcher at the University of Arizona is spearheading an effort to come up with a reliable way to catch ovarian cancer in its earliest stages. 

From airport baggage screeners to assembly-line inspectors, humans tasked with repetitively or continuously scrutinizing separate but similar visuals for hours on end tend to lose their focus bit by bit. The effect is called vigilance decrement. Does it affect screening-mammography readers to a dangerous degree?